TAVRにおけるサブ臨床的小葉書血栓症およびサブ臨床的大動脈弁複合血栓症
Benjamin Marchandot1, Antonin Trimaille1, Shinnosuke Kikuchi2
1Department of Cardiology, University Hospital of Strasbourg, Strasbourg, France; Research Unit - UR3074 - Translational Cardiovascular Medicine, University of Strasbourg, Strasbourg, France; GERCA (Groupe pour l'Enseignement et la Recherche Cardiologique en Alsace), Strasbourg, France.
JACC. Advances
|August 21, 2025
まとめ
トランスキャテーターによる大動脈弁置換後のサブ臨床的小葉書血栓症 (SLT) は一般的です. 抗凝固策の最適化により,SLTの減少と出血リスクのバランスをとることで,患者の治療結果が改善されます.
科学分野:
- 心臓病科
- 生物医学工学
背景:
- トランスキャテーターによる大動脈弁置換 (TAVR) の後の患者の10~30%がサブクリニカル・リーフレット・トロンボシス (SLT) に罹患しています.
- SLTは外膜領域に広がり,亜臨床的な大動脈弁複合血栓を形成する.
- TAVRの合併症の管理には,SLTの多因子の理解が不可欠です.
研究 の 目的:
- TAVR の後に SLT に寄与する要因をレビューする.
- SLT の発生に対する抗血栓治療の影響を分析する.
- 高リスクの患者に個別化された抗凝固策を提案する.
主な方法:
- SLT に寄与する要因に関する包括的な文献レビュー.
- バルブ特有のパラメータの分析:フローダイナミクス,義肢サイズ,展開,並べ替え.
- 保存されたカルシフィエット葉書の活性と抗血栓治療効果の評価
主要な成果:
- 1ヶ月後のSLTの発生率は10~15%から,TAVRの1年後の30%までです.
- 経口抗凝固薬は検出されたSLTを減少させますが,出血と死亡リスクを増加させます.
- 装置の幾何学,鼻腔の流れ,本来の組織活動が,SLTの重要な決定因子である.
結論:
- 高リスクのTAVR患者には,個別化された,時間限定の抗凝固策が必要である.
- TAVRの改善には,血栓と出血のバランスを最適化することが不可欠です.
- デバイス,フロー,組織要素を統合することで, 適合した抗凝固治療を導くことができます.
関連する概念動画
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
22
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
22
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
01:15Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
01:27Mitral Valve Prolapse I: Introduction
42
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
42
01:25Aortic Regurgitation III: Medical Management
42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42